DCF — KAPIOLANI MED CTR FOR WOMEN & CHILDR
Enterprise Value: $456.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$456.0M
Enterprise Value
$123.3M
PV of Cash Flows
$332.7M
PV of Terminal Value
$535.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $450.5M | $55.7M | 12.0% | $25.5M | $23.2M |
| Year 2 | $464.1M | $62.0M | 13.0% | $29.8M | $24.6M |
| Year 3 | $478.0M | $68.7M | 14.0% | $34.3M | $25.7M |
| Year 4 | $492.3M | $73.2M | 15.0% | $37.1M | $25.4M |
| Year 5 | $507.1M | $76.7M | 15.0% | $39.2M | $24.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $456.0M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$437.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.11868831042826669
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5